(1)
WAYHS, C. A. .; Von DIEMEN, T. Pharmacovigilance Program Impact on Notifications of Adverse Reactions to Antineoplastic Drug in a University Hospital. J Hosp Pharm Health Serv 2024, 15, e1118.